Aug 9, 2022
In this episode, Ashlie Leal, director of
ophthalmology at FundamentalVR, discusses their fully immersive
surgical training products, how virtual reality plays a role in
training surgeons and more.
- Intro :38
- Welcome to another episode of Eye Care insider
:52
- About Ashlie Leal 1:00
- Give me a little bit of your background – how you got into this
industry and your role at FundamentalVR?
1:33
- Can you give our listeners some background about FundamentalVR
as a company, and why should eye care professionals start paying
attention to your company? 2:56
- Do you target training programs? … Is there a certain focus to
your company in regards to demographics?
4:12
- Is there any way you can describe [your virtual reality
products] or any current product offers that you have that apply to
eye care professionals? 7:30
- You’re using a headset and the two arms. Is that all you would
need, or would you need some sort of base mannequin head with an
eyeball simulation? 9:25
- You can do it anywhere, theoretically? And you can simulate
different MIGS equipment and different ocular lens implants based
on the tech simulating that equipment?
10:59
- So, the simulation is able to carry out these multiple,
intricate steps? 12:03
- Is there current gene therapy that is utilizing your
technology? Do you have a relationship with them in the sense that
you provide the surgeons with the virtual reality simulations?
12:49
- Do you have any sort of data or any procedure done with virtual
reality improving complication rate and efficiency?
14:02
- What does the future look like for virtual reality? What would
you say is the major challenge, or what does your company hope to
accomplish in the next few years or the decade?
15:30
- What’s that process look like for a company to approach you for
virtual reality offering to train on a new device? How long does
that process take, and what are the steps to assimilate their
product into your technology? 17:14
- If someone wants to learn more, how can they contact you or
your company for more information?
19:13
- Congratulations Ashlie and FundamentalVR
19:39
- Any final words to our listeners?
20:02
- Outro 20:39
Ashlie Leal is director of ophthalmology,
FundamentalVR.
We’d love to hear from you! Send your comments/questions to Dr.
Mali at eyecareinsider@healio.com.
Follow us on Twitter @Healio_OSN. Leal can be
reached on LinkedIn or at www.fundamentalsurgery.com.
Disclosures: Mali reports he is founder and CEO
of Mali Enterprises; retina medical director at Macular
Degeneration Association; grant/research support from Alimera
Sciences, Allergan/AbbVie, Chengdu Kanghong Biotechnology,
Genentech, Notal Vision, Regeneron and Santen; consulting for
Alimera Sciences, Allergan/AbbVie, Eyepoint Pharmaceuticals,
Genentech, Kala Pharmaceuticals, Macular Degeneration Association,
Notal Vision, Novartis, Regeneron and Sun Pharmaceuticals; speaker
bureau for Alimera Sciences, Genentech, Kala Pharmaceuticals,
Macular Degeneration Association, Notal Vision, Novartis and Sun
Pharmaceuticals; and stock/shareholder with AbbVie and Regeneron.
Leal reports she is director of ophthalmology at FundamentalVR.